AAPL312.42+3.79 (+1.23%) ▲|ABBV256.39-4.68 (-1.79%) ▼|ABT95.72+0.32 (+0.34%) ▲|ACN136.93-0.42 (-0.31%) ▼|ADBE218.15-1.58 (-0.72%) ▼|AMAT595.55-7.49 (-1.24%) ▼|AMD553.13+35.31 (+6.82%) ▲|AMGN365.56-8.59 (-2.30%) ▼|AMT161.30-4.73 (-2.85%) ▼|AMZN244.91+2.24 (+0.92%) ▲|AVGO375.77+15.32 (+4.25%) ▲|AXP356.44+4.48 (+1.27%) ▲|BA232.73+6.24 (+2.76%) ▲|BAC59.83+1.10 (+1.86%) ▲|BKNG182.35-2.21 (-1.20%) ▼|BLK1,004.88+9.15 (+0.92%) ▲|BMY56.89-1.25 (-2.14%) ▼|BNY149.66+3.04 (+2.07%) ▲|BRK-B506.99-0.79 (-0.16%) ▼|C142.98+3.01 (+2.15%) ▲|CAT971.51+7.98 (+0.83%) ▲|CL93.09-2.05 (-2.15%) ▼|CMCSA23.56-0.24 (-0.99%) ▼|COF206.01+0.89 (+0.43%) ▲|COP103.87-0.86 (-0.82%) ▼|COST947.13-4.55 (-0.48%) ▼|CRM166.34+0.23 (+0.14%) ▲|CSCO114.07+1.38 (+1.22%) ▲|CVS102.39-2.33 (-2.23%) ▼|CVX168.18-1.02 (-0.60%) ▼|DE632.31+11.04 (+1.78%) ▲|DHR194.61-3.33 (-1.68%) ▼|DIS97.42-2.08 (-2.09%) ▼|DUK126.56-3.05 (-2.35%) ▼|EMR141.38+2.33 (+1.68%) ▲|FDX309.18-3.83 (-1.22%) ▼|GD376.19+2.65 (+0.71%) ▲|GE378.28+1.23 (+0.32%) ▲|GEV1,155.55+42.44 (+3.81%) ▲|GILD129.15-2.12 (-1.62%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG361.64+5.46 (+1.53%) ▲|GOOGL364.27+4.36 (+1.21%) ▲|GS1,045.02+24.02 (+2.35%) ▲|HD352.09-5.81 (-1.62%) ▼|HON228.18-1.69 (-0.73%) ▼|IBM297.98+8.46 (+2.92%) ▲|INTC122.73+2.38 (+1.98%) ▲|INTU270.61-4.74 (-1.72%) ▼|ISRG437.15+11.14 (+2.62%) ▲|JNJ259.24-3.81 (-1.45%) ▼|JPM337.04+4.07 (+1.22%) ▲|KO83.30-0.84 (-1.00%) ▼|LIN536.71-9.93 (-1.82%) ▼|LLY1,207.78-6.13 (-0.51%) ▼|LMT538.28-7.63 (-1.40%) ▼|LOW224.20-3.30 (-1.45%) ▼|LRCX351.23-0.18 (-0.05%) ▼|MA533.55-5.84 (-1.08%) ▼|MCD278.06-2.57 (-0.92%) ▼|MDLZ59.25-1.66 (-2.73%) ▼|MDT83.65+0.46 (+0.55%) ▲|META594.14+11.24 (+1.93%) ▲|MMM158.53-1.92 (-1.19%) ▼|MO72.13-0.59 (-0.80%) ▼|MRK126.77-2.79 (-2.15%) ▼|MS220.51+6.58 (+3.08%) ▲|MSFT384.73-5.76 (-1.48%) ▼|MU986.17+10.61 (+1.09%) ▲|NEE87.59-0.75 (-0.85%) ▼|NFLX76.15-1.51 (-1.94%) ▼|NKE43.08-1.01 (-2.29%) ▼|NOW108.57+2.25 (+2.12%) ▲|NVDA195.70+0.87 (+0.45%) ▲|ORCL143.07+2.80 (+2.00%) ▲|PEP143.13-1.09 (-0.76%) ▼|PFE23.83-0.50 (-2.04%) ▼|PG148.92-2.49 (-1.64%) ▼|PLTR131.43+2.13 (+1.64%) ▲|PM184.74+2.47 (+1.36%) ▲|QCOM185.57+9.32 (+5.29%) ▲|RTX200.91+1.66 (+0.83%) ▲|SBUX101.32-2.96 (-2.83%) ▼|SCHW100.79+3.79 (+3.91%) ▲|SO96.14-1.84 (-1.88%) ▼|SPG224.87-1.19 (-0.53%) ▼|T20.57-0.02 (-0.07%) ▼|TMO516.75-6.69 (-1.28%) ▼|TMUS181.37+3.85 (+2.17%) ▲|TSLA415.09+21.64 (+5.50%) ▲|TXN303.30+10.22 (+3.49%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH417.35-8.01 (-1.88%) ▼|UNP282.40+0.15 (+0.05%) ▲|UPS110.05-0.61 (-0.55%) ▼|USB63.01+1.28 (+2.07%) ▲|V357.53-4.61 (-1.27%) ▼|VZ41.98-0.59 (-1.37%) ▼|WFC87.53+2.02 (+2.36%) ▲|WMT110.44-1.40 (-1.25%) ▼|XOM136.98-0.11 (-0.08%) ▼|AAPL312.42+3.79 (+1.23%) ▲|ABBV256.39-4.68 (-1.79%) ▼|ABT95.72+0.32 (+0.34%) ▲|ACN136.93-0.42 (-0.31%) ▼|ADBE218.15-1.58 (-0.72%) ▼|AMAT595.55-7.49 (-1.24%) ▼|AMD553.13+35.31 (+6.82%) ▲|AMGN365.56-8.59 (-2.30%) ▼|AMT161.30-4.73 (-2.85%) ▼|AMZN244.91+2.24 (+0.92%) ▲|AVGO375.77+15.32 (+4.25%) ▲|AXP356.44+4.48 (+1.27%) ▲|BA232.73+6.24 (+2.76%) ▲|BAC59.83+1.10 (+1.86%) ▲|BKNG182.35-2.21 (-1.20%) ▼|BLK1,004.88+9.15 (+0.92%) ▲|BMY56.89-1.25 (-2.14%) ▼|BNY149.66+3.04 (+2.07%) ▲|BRK-B506.99-0.79 (-0.16%) ▼|C142.98+3.01 (+2.15%) ▲|CAT971.51+7.98 (+0.83%) ▲|CL93.09-2.05 (-2.15%) ▼|CMCSA23.56-0.24 (-0.99%) ▼|COF206.01+0.89 (+0.43%) ▲|COP103.87-0.86 (-0.82%) ▼|COST947.13-4.55 (-0.48%) ▼|CRM166.34+0.23 (+0.14%) ▲|CSCO114.07+1.38 (+1.22%) ▲|CVS102.39-2.33 (-2.23%) ▼|CVX168.18-1.02 (-0.60%) ▼|DE632.31+11.04 (+1.78%) ▲|DHR194.61-3.33 (-1.68%) ▼|DIS97.42-2.08 (-2.09%) ▼|DUK126.56-3.05 (-2.35%) ▼|EMR141.38+2.33 (+1.68%) ▲|FDX309.18-3.83 (-1.22%) ▼|GD376.19+2.65 (+0.71%) ▲|GE378.28+1.23 (+0.32%) ▲|GEV1,155.55+42.44 (+3.81%) ▲|GILD129.15-2.12 (-1.62%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG361.64+5.46 (+1.53%) ▲|GOOGL364.27+4.36 (+1.21%) ▲|GS1,045.02+24.02 (+2.35%) ▲|HD352.09-5.81 (-1.62%) ▼|HON228.18-1.69 (-0.73%) ▼|IBM297.98+8.46 (+2.92%) ▲|INTC122.73+2.38 (+1.98%) ▲|INTU270.61-4.74 (-1.72%) ▼|ISRG437.15+11.14 (+2.62%) ▲|JNJ259.24-3.81 (-1.45%) ▼|JPM337.04+4.07 (+1.22%) ▲|KO83.30-0.84 (-1.00%) ▼|LIN536.71-9.93 (-1.82%) ▼|LLY1,207.78-6.13 (-0.51%) ▼|LMT538.28-7.63 (-1.40%) ▼|LOW224.20-3.30 (-1.45%) ▼|LRCX351.23-0.18 (-0.05%) ▼|MA533.55-5.84 (-1.08%) ▼|MCD278.06-2.57 (-0.92%) ▼|MDLZ59.25-1.66 (-2.73%) ▼|MDT83.65+0.46 (+0.55%) ▲|META594.14+11.24 (+1.93%) ▲|MMM158.53-1.92 (-1.19%) ▼|MO72.13-0.59 (-0.80%) ▼|MRK126.77-2.79 (-2.15%) ▼|MS220.51+6.58 (+3.08%) ▲|MSFT384.73-5.76 (-1.48%) ▼|MU986.17+10.61 (+1.09%) ▲|NEE87.59-0.75 (-0.85%) ▼|NFLX76.15-1.51 (-1.94%) ▼|NKE43.08-1.01 (-2.29%) ▼|NOW108.57+2.25 (+2.12%) ▲|NVDA195.70+0.87 (+0.45%) ▲|ORCL143.07+2.80 (+2.00%) ▲|PEP143.13-1.09 (-0.76%) ▼|PFE23.83-0.50 (-2.04%) ▼|PG148.92-2.49 (-1.64%) ▼|PLTR131.43+2.13 (+1.64%) ▲|PM184.74+2.47 (+1.36%) ▲|QCOM185.57+9.32 (+5.29%) ▲|RTX200.91+1.66 (+0.83%) ▲|SBUX101.32-2.96 (-2.83%) ▼|SCHW100.79+3.79 (+3.91%) ▲|SO96.14-1.84 (-1.88%) ▼|SPG224.87-1.19 (-0.53%) ▼|T20.57-0.02 (-0.07%) ▼|TMO516.75-6.69 (-1.28%) ▼|TMUS181.37+3.85 (+2.17%) ▲|TSLA415.09+21.64 (+5.50%) ▲|TXN303.30+10.22 (+3.49%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH417.35-8.01 (-1.88%) ▼|UNP282.40+0.15 (+0.05%) ▲|UPS110.05-0.61 (-0.55%) ▼|USB63.01+1.28 (+2.07%) ▲|V357.53-4.61 (-1.27%) ▼|VZ41.98-0.59 (-1.37%) ▼|WFC87.53+2.02 (+2.36%) ▲|WMT110.44-1.40 (-1.25%) ▼|XOM136.98-0.11 (-0.08%) ▼|
21 C
New York
Monday, July 6, 2026

Tag: offer

newssourceFORcompanyinformationcontent1releasesmarket

Golden Gas Announces Open Season for Joy Station Storage Project in Kansas

TULSA, Okla., June 16, 2025 /PRNewswire/ -- Golden Gas Service Company ("Golden Gas") today announced the launch of a non-binding open season to solicit market...

Cortizone-10® Partners with Dylan Efron and the National Park Foundation to Help Outdoor Enthusiasts Stay Itch-Free This Summer

The brand's new Itch Relief Cooling Spray helps tackle "itchsanity" one irritation at a time. MORRISTOWN, N.J., June 16, 2025 /PRNewswire/ -- Whether it's a...

Choose Canada this summer with the new Canada Strong Pass

From June 20 to September 2, 2025, the Canada Strong Pass will offer expanded access to numerous natural and cultural experiences across the country OTTAWA,...

Sprott Physical Uranium Trust Announces Upsized US$200 Million Bought Deal Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR...

JAPAN HOUSE Los Angeles Welcomes its Millionth Visitor

LA Cultural Destination has Sparked Cross-Cultural Exchange Since 2018,
From Space Exploration and Business Sustainability Programs, to Film Talks,
Hands-On Workshops, and Exhibitions Showcasing Intergenerational Traditions

Baker Hughes to Acquire Continental Disc Corporation, a Differentiated Leader in Pressure Management Solutions

HOUSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Monday it has agreed to acquire Continental Disc Corporation (CDC), a leading provider of safety-critical pressure management solutions, from investment partnerships managed by Tinicum Incorporated in an all-cash transaction for approximately $540 million.

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

WILMINGTON, Del., June 16, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE...

LITTLE CAESARS® TEAMS UP WITH MARVEL STUDIOS’ “THE FANTASTIC FOUR: FIRST STEPS”

Chain launches deliciously unique Fantastic Four-N-One pizza ahead of the film's release   OAKVILLE, ON, June 16, 2025 /CNW/ -- Little Caesars is bringing fantastic variety to...

Netskope Strengthens Relationship with Microsoft to Streamline Data Discovery, Classification, and Protection Across the Enterprise

Seamless integration of Netskope One capabilities with Microsoft tools delivers flexibility and best-in-class security for modern AI and cloud environments SANTA CLARA, Calif., June 16, 2025...

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate...

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retinopathies). The FDA previously granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation for OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa 19, and cone-rod dystrophy 3.

VEON Announces USD 35 Million Share Buyback

Announcement marks the third phase of USD 100 million share buyback program 

LNG Station Market worth $1.56 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., June 16, 2025 /PRNewswire/ -- The global LNG Station Market is anticipated to grow from estimated USD 1.02 billion in 2025 to...

Nobel Economists Advocate Passive Investing—Reviewing Evidence Against Active Management

In the realm of investment, empirical evidence plays a pivotal role in shaping sound strategies. Nobel Prize-winning research provides robust insights that directly challenge...

RayStation used for pioneering clinical milestone at Helsinki University Hospital – first treatment with accelerator-based BNCT in Europe

STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOffer

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers